188 related articles for article (PubMed ID: 18026104)
1. Loss of Trim24 (Tif1alpha) gene function confers oncogenic activity to retinoic acid receptor alpha.
Khetchoumian K; Teletin M; Tisserand J; Mark M; Herquel B; Ignat M; Zucman-Rossi J; Cammas F; Lerouge T; Thibault C; Metzger D; Chambon P; Losson R
Nat Genet; 2007 Dec; 39(12):1500-6. PubMed ID: 18026104
[TBL] [Abstract][Full Text] [Related]
2. Tripartite motif 24 (Trim24/Tif1α) tumor suppressor protein is a novel negative regulator of interferon (IFN)/signal transducers and activators of transcription (STAT) signaling pathway acting through retinoic acid receptor α (Rarα) inhibition.
Tisserand J; Khetchoumian K; Thibault C; Dembélé D; Chambon P; Losson R
J Biol Chem; 2011 Sep; 286(38):33369-79. PubMed ID: 21768647
[TBL] [Abstract][Full Text] [Related]
3. Trim24 (Tif1 alpha): an essential 'brake' for retinoic acid-induced transcription to prevent liver cancer.
Khetchoumian K; Teletin M; Tisserand J; Herquel B; Ouararhni K; Losson R
Cell Cycle; 2008 Dec; 7(23):3647-52. PubMed ID: 19029830
[TBL] [Abstract][Full Text] [Related]
4. Trim24-repressed VL30 retrotransposons regulate gene expression by producing noncoding RNA.
Herquel B; Ouararhni K; Martianov I; Le Gras S; Ye T; Keime C; Lerouge T; Jost B; Cammas F; Losson R; Davidson I
Nat Struct Mol Biol; 2013 Mar; 20(3):339-46. PubMed ID: 23377542
[TBL] [Abstract][Full Text] [Related]
5. Transcription cofactors TRIM24, TRIM28, and TRIM33 associate to form regulatory complexes that suppress murine hepatocellular carcinoma.
Herquel B; Ouararhni K; Khetchoumian K; Ignat M; Teletin M; Mark M; Béchade G; Van Dorsselaer A; Sanglier-Cianférani S; Hamiche A; Cammas F; Davidson I; Losson R
Proc Natl Acad Sci U S A; 2011 May; 108(20):8212-7. PubMed ID: 21531907
[TBL] [Abstract][Full Text] [Related]
6. TRIM24 suppresses development of spontaneous hepatic lipid accumulation and hepatocellular carcinoma in mice.
Jiang S; Minter LC; Stratton SA; Yang P; Abbas HA; Akdemir ZC; Pant V; Post S; Gagea M; Lee RG; Lozano G; Barton MC
J Hepatol; 2015 Feb; 62(2):371-9. PubMed ID: 25281858
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of retinoid X receptor suppresses its ubiquitination in human hepatocellular carcinoma.
Adachi S; Okuno M; Matsushima-Nishiwaki R; Takano Y; Kojima S; Friedman SL; Moriwaki H; Okano Y
Hepatology; 2002 Feb; 35(2):332-40. PubMed ID: 11826406
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of retinoic acid receptor alpha in hepatocellular carcinoma.
Sano K; Takayama T; Murakami K; Saiki I; Makuuchi M
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3679-83. PubMed ID: 14506158
[TBL] [Abstract][Full Text] [Related]
9. Oncogenic potential of retinoic acid receptor-gamma in hepatocellular carcinoma.
Yan TD; Wu H; Zhang HP; Lu N; Ye P; Yu FH; Zhou H; Li WG; Cao X; Lin YY; He JY; Gao WW; Zhao Y; Xie L; Chen JB; Zhang XK; Zeng JZ
Cancer Res; 2010 Mar; 70(6):2285-95. PubMed ID: 20197465
[TBL] [Abstract][Full Text] [Related]
10. Potential functions of retinoic acid receptor A in Sertoli cells and germ cells during spermatogenesis.
Doyle TJ; Braun KW; McLean DJ; Wright RW; Griswold MD; Kim KH
Ann N Y Acad Sci; 2007 Dec; 1120():114-30. PubMed ID: 17905941
[TBL] [Abstract][Full Text] [Related]
11. Neuron-derived orphan receptor 1 promotes proliferation of quiescent hepatocytes.
Vacca M; Murzilli S; Salvatore L; Di Tullio G; D'Orazio A; Lo Sasso G; Graziano G; Pinzani M; Chieppa M; Mariani-Costantini R; Palasciano G; Moschetta A
Gastroenterology; 2013 Jun; 144(7):1518-1529.e3. PubMed ID: 23462179
[TBL] [Abstract][Full Text] [Related]
12. Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL.
He LZ; Guidez F; Tribioli C; Peruzzi D; Ruthardt M; Zelent A; Pandolfi PP
Nat Genet; 1998 Feb; 18(2):126-35. PubMed ID: 9462740
[TBL] [Abstract][Full Text] [Related]
13. A developmental transition in definitive erythropoiesis: erythropoietin expression is sequentially regulated by retinoic acid receptors and HNF4.
Makita T; Hernandez-Hoyos G; Chen TH; Wu H; Rothenberg EV; Sucov HM
Genes Dev; 2001 Apr; 15(7):889-901. PubMed ID: 11297512
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation of retinoid X receptor alpha at serine 260 impairs its metabolism and function in human hepatocellular carcinoma.
Matsushima-Nishiwaki R; Okuno M; Adachi S; Sano T; Akita K; Moriwaki H; Friedman SL; Kojima S
Cancer Res; 2001 Oct; 61(20):7675-82. PubMed ID: 11606411
[TBL] [Abstract][Full Text] [Related]
15. A RA-dependent, tumour-growth suppressive transcription complex is the target of the PML-RARalpha and T18 oncoproteins.
Zhong S; Delva L; Rachez C; Cenciarelli C; Gandini D; Zhang H; Kalantry S; Freedman LP; Pandolfi PP
Nat Genet; 1999 Nov; 23(3):287-95. PubMed ID: 10610177
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanism for growth suppression of human hepatocellular carcinoma cells by acyclic retinoid.
Matsushima-Nishiwaki R; Okuno M; Takano Y; Kojima S; Friedman SL; Moriwaki H
Carcinogenesis; 2003 Aug; 24(8):1353-9. PubMed ID: 12807734
[TBL] [Abstract][Full Text] [Related]
17. Critical role of PA28gamma in hepatitis C virus-associated steatogenesis and hepatocarcinogenesis.
Moriishi K; Mochizuki R; Moriya K; Miyamoto H; Mori Y; Abe T; Murata S; Tanaka K; Miyamura T; Suzuki T; Koike K; Matsuura Y
Proc Natl Acad Sci U S A; 2007 Jan; 104(5):1661-6. PubMed ID: 17234812
[TBL] [Abstract][Full Text] [Related]
18. The gene encoding human retinoic acid-receptor-related orphan receptor alpha is a target for hypoxia-inducible factor 1.
Chauvet C; Bois-Joyeux B; Berra E; Pouyssegur J; Danan JL
Biochem J; 2004 Nov; 384(Pt 1):79-85. PubMed ID: 15270719
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the retinoic acid receptor alpha gene as a candidate for the pulmonary adenoma resistance 1 gene.
Gariboldi M; Vivat V; De Gregorio L; Manenti G; Chiariello E; Falvella FS; Pierotti MA; Dragani TA
Mol Carcinog; 1998 Jan; 21(1):13-6. PubMed ID: 9473767
[TBL] [Abstract][Full Text] [Related]
20. Retinoic acid receptor alpha dominant negative form causes steatohepatitis and liver tumors in transgenic mice.
Yanagitani A; Yamada S; Yasui S; Shimomura T; Murai R; Murawaki Y; Hashiguchi K; Kanbe T; Saeki T; Ichiba M; Tanabe Y; Yoshida Y; Morino S; Kurimasa A; Usuda N; Yamazaki H; Kunisada T; Ito H; Murawaki Y; Shiota G
Hepatology; 2004 Aug; 40(2):366-75. PubMed ID: 15368441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
